These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32375331)

  • 21. Breakthrough Cancer Pain: Ten Commandments.
    Mercadante S; Cuomo A
    Value Health; 2016; 19(5):531-6. PubMed ID: 27565269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain.
    Ueberall MA; Lorenzl S; Lux EA; Voltz R; Perelman M
    J Pain Res; 2016; 9():571-85. PubMed ID: 27574463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study.
    Mercadante S; Adile C; Cuomo A; Aielli F; Cortegiani A; Casuccio A; Porzio G
    J Pain Symptom Manage; 2015 Nov; 50(5):579-86. PubMed ID: 26303188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study.
    Mercadante S; Aielli F; Adile C; Costanzi A; Casuccio A
    J Pain Symptom Manage; 2016 Jul; 52(1):27-34. PubMed ID: 27208863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
    Magnani C; Giannarelli D; Calvieri A; Dardeli A; Eusepi G; Restuccia MR; Mastroianni C; Casale G
    Postgrad Med J; 2018 Oct; 94(1116):566-570. PubMed ID: 30317182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study.
    Fallon M; Reale C; Davies A; Lux AE; Kumar K; Stachowiak A; Galvez R;
    J Support Oncol; 2011; 9(6):224-31. PubMed ID: 22055892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy.
    Ferrero VT; Oset MM; Masferrer JP; Pardo EH; Sorolla EJ; Largo SC;
    Clin Transl Oncol; 2019 Dec; 21(12):1707-1711. PubMed ID: 30949931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.
    Canal-Sotelo J; Trujillano-Cabello J; Larkin P; Arraràs-Torrelles N; González-Rubió R; Rocaspana-Garcia M; Barallat-Gimeno E
    BMC Palliat Care; 2018 May; 17(1):81. PubMed ID: 29807537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakthrough pain in patients with abdominal cancer pain.
    Mercadante S; Adile C; Giarratano A; Casuccio A
    Clin J Pain; 2014 Jun; 30(6):510-4. PubMed ID: 24281289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating breakthrough pain in oncology.
    Mercadante S
    Expert Rev Anticancer Ther; 2018 May; 18(5):445-449. PubMed ID: 29478355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canadian recommendations for the management of breakthrough cancer pain.
    Daeninck P; Gagnon B; Gallagher R; Henderson JD; Shir Y; Zimmermann C; Lapointe B
    Curr Oncol; 2016 Apr; 23(2):96-108. PubMed ID: 27122974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient Satisfaction with Fentanyl Sublingual Spray in Opioid-Tolerant Patients with Breakthrough Cancer Pain.
    Rauck R; Parikh N; Dillaha L; Barker J; Stearns L
    Pain Pract; 2015 Jul; 15(6):554-63. PubMed ID: 25060406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain.
    Überall MA; Müller-Schwefe GH
    Curr Med Res Opin; 2011 Jul; 27(7):1385-94. PubMed ID: 21561313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials.
    Jandhyala R; Fullarton JR; Bennett MI
    J Pain Symptom Manage; 2013 Oct; 46(4):573-80. PubMed ID: 23380337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.
    Cortesi PA; D'Angiolella LS; Vellucci R; Allegri M; Casale G; Favaretti C; Kheiraoui F; Cesana G; Mantovani LG
    PLoS One; 2017; 12(6):e0179523. PubMed ID: 28654672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study.
    Tekie Y; Nigatu YA; Mekonnen W; Berhe YW
    Front Oncol; 2023; 13():1248921. PubMed ID: 38264754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxycodone/Acetaminophen: The Tailoring Combination Treatment for Specific Clinical Profile of Opioid Well-Responsive Cancer Pain.
    De Santis S; Simone MD; Mercadante S; Mediati RD; Vellucci R; Marchetti P; Tonini G; Cuomo A; Caraceni A; Natoli S; Armento G; Blasi L; Mammucari M;
    Cancer Manag Res; 2021; 13():1747-1756. PubMed ID: 33642876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current management of breakthrough cancer pain according to physicians from pain units in Spain.
    Estévez FV; Alarcón MDL; Mayoral V; de Madariaga M; Margarit C; Duran JA; Martín-Arroyo JMT; Carregal A;
    Clin Transl Oncol; 2019 Sep; 21(9):1168-1176. PubMed ID: 30783918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breakthrough cancer pain (BTcP) management: a review of international and national guidelines.
    Davies AN; Elsner F; Filbet MJ; Porta-Sales J; Ripamonti C; Santini D; Webber K
    BMJ Support Palliat Care; 2018 Sep; 8(3):241-249. PubMed ID: 29875184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice.
    Bossi P; Escobar Y; Pea F
    Front Pain Res (Lausanne); 2022; 3():893530. PubMed ID: 35721659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.